Skip to search formSkip to main contentSkip to account menu

Benserazide / Levodopa

Known as: benserazide, levodopa drug combination, benserazide - levodopa, co-beneldopa 
National Institutes of Health

Related topics

Related topics

6 relations
BenserazideLevodopa

Broader (3)

Dopaminergic AgentsDrug CombinationsEnzyme Inhibitors

Narrower (1)

Madopar

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Novel SERAC1 mutations in a Chinese patient presenting with parkinsonism and dystonia
A 22-year-old man was admitted to our hospital complaining of bradykinesia of the limbs, abnormal posture of neck and feet, and… 
2004
2004
Clinical efficacy of selegiline combined with benserazide-levodopa in treating Parkinson disease
1977
1977
Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension
SummaryIn a single-blind study, the dopa-decarboxylase inhibitor benserazide (375 mg/day for 3 days and 750 mg/day for further 3… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)